Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference61 articles.
1. MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer;Abdallah;Int. J. Cancer,2016
2. Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity;Abuznait;J. Pharm. Pharm. Sci.,2011
3. Targeted therapies for advanced non-small cell lung cancer;Ai;Oncotarget,2018
4. Overcoming ABC transporter-mediated multidrug resistance: the dual role of tyrosine kinase inhibitors as multitargeting agents;Beretta;Eur. J. Med. Chem.,2017
5. The protein data bank;Berman;Nucleic Acids Res.,2000
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo;Biochemical Pharmacology;2023-10
2. Prediction of prognosis and immune landscape in cervical cancer based on heat shock protein-related genes;International Journal of Hyperthermia;2023-09-26
3. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters;Nature Reviews Cancer;2023-09-15
4. Significance of platelet adhesion-related genes in colon cancer based on non-negative matrix factorization-based clustering algorithm;DIGITAL HEALTH;2023-01
5. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response;Biomedicine & Pharmacotherapy;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3